Opportunity ID: 138633

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: RFA-HL-13-005
Funding Opportunity Title:: Excellence in Hemoglobinopathies Research Award (EHRA) (U54)
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Health
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s):: 93.839 — Blood Diseases and Resources Research
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 1
Posted Date:: Jan 18, 2012
Last Updated Date::
Original Closing Date for Applications:: May 08, 2012
Current Closing Date for Applications:: May 08, 2012
Archive Date:: Jun 08, 2012
Estimated Total Program Funding:: $ 14,000,000
Award Ceiling:: $150,000
Award Floor:: $

Eligibility

Eligible Applicants:: County governments
Additional Information on Eligibility:: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name:: National Institutes of Health
Description:: This Funding Opportunity Announcement (FOA) solicits five-year Cooperative Agreement (U54) grant applications to the Excellence in Hemoglobinopathies Research Award (EHRA) program. The primary objective of this new program is to support the development of studies that will accelerate high-impact multi-disciplinary basic and translational research in the hemoglobinopathies and facilitate maximal collaborations among basic and translational scientists and clinical hematologists located throughout the US or at international sites. An application must propose a single project that approaches a common scientific theme through innovative collaborations among investigators in two or more relevant disciplines, providing opportunities for research which will translate basic observations to applied clinical research.
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 1

Package Status

Package No: 1

Related Documents